
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc. is poised for a positive financial outlook due to its strong positioning within the rapidly growing behavioral health sector, where it has generated impressive organic growth through facility expansions and new developments. The expectation of a notable increase in net PLGL liability by the end of 2025, along with guidance for improved organic earnings growth, highlights the company's strategic focus on expanding its service capacity while navigating operational challenges. Additionally, the strong capitalization facilitates potential mergers and acquisitions, further positioning the company to enhance its market presence amid competitive conditions in the behavioral healthcare market.
Bears say
Acadia Healthcare Co Inc has lowered its EBITDA guidance for 2025 by approximately $94 million, or 13.4%, to a range of $601-611 million due to higher-than-expected PLGL expenses, which are projected to persist through 2026. The company anticipates a contraction in EBITDA for fiscal year 2026, estimating it at $626.6 million, down from a previous estimate of $664.6 million, which reflects ongoing litigation expenses that are significantly above historical norms. Moreover, the downside scenario suggests that volume softness could lead to EBITDA coming in 5% below current projections, resulting in a lower valuation multiple that is concerning for the company's long-term financial health.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares